ED
Eric M Dube (CHIEF EXECUTIVE OFFICER) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $25.4M of TVTX (399,730 sh across 7 lots, as filed), executed Sep 15. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$50.8M
shares × price, as filed
Last traded
Oct 15
Filed Oct 19
Median ADV $123.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $56.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
TVTXRecent filings
TVTXSALE
Travere Therapeutics, Inc.
View filing →
$3.6M120,000 sh across 2 lots
Exec Oct 28 2025
Filed Oct 30 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $398K
18,924 sh × $21.05
Exec May 5 2025
Filed May 5 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $273K
11,375 sh × $24.04
Exec Feb 11 2025
Filed Feb 12 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $1.0M
50,691 sh × $20.21
Exec Feb 3 2025
Filed Feb 4 2025 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. View filing → $209K
10,736 sh × $19.46
Exec Jan 22 2025
Filed Jan 23 2025 · 5:30 PM ET